論文

2021 英文

TITLE & JOURNAL/AUTHORS

Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C
著者名：Takemura K, Takizawa E, Tamori A, Nakamae M, Kubota H, Uchida-Kobayashi S, Enomoto M, Kawada N, Hino M.
出版物名：J Gastroenterol Hepatol. 2021 Jan;36(1):217-224. doi: 10.1111/jgh.15114. Epub 2020 Jun 12.
Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants
著者名：Yoshida K, Desbiolles A, Feldman SF, Ahn SH, Alidjinou EK, Atsukawa M, Bocket L, Brunetto MR, Buti M, Carey I, Caviglia GP, Chen EQ, Cornberg M, Enomoto M, Honda M, Zu Siederdissen CH, Ishigami M, Janssen HLA, Maasoumy B, Matsui T, Matsumoto A, Nishiguchi S, Riveiro-Barciela M, Takaki A, Tangkijvanich P, Toyoda H, van Campenhout MJH, Wang B, Wei L, Yang HI, Yano Y, Yatsuhashi H, Yuen MF, Tanaka E, Lemoine M, Tanaka Y, Shimakawa Y.
出版物名：Clin Gastroenterol Hepatol. 2021 Jan;19(1):46-60.e8. doi: 10.1016/j.cgh.2020.04.045. Epub 2020 Apr 29.
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
著者名：Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T.
出版物名：J Gastroenterol. 2021 Jan;56(1):67-77. doi: 10.1007/s00535-020-01733-4.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
著者名：Kudo M, Tsuchiya K, Kato N, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Furuse J, Ikeda M, Morimoto M, Achira M, Kuroda S, Kimura A.
出版物名：J Gastroenterol. 2021 Feb;56(2):181-190. doi: 10.1007/s00535-020-01753-0. Epub 2021 Jan 3.
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
著者名：Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld.
出版物名：Life (Basel). 2021 Feb 14;11(2):143. doi: 10.3390/life11020143.
Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma
著者名：Suoh M, Hagihara A, Yamamura M, Maruyama H, Taira K, Enomoto M, Tamori A, Fujiwara Y, Kawada N.
出版物名：Intern Med. 2021 Feb 15;60(4):545-552. doi: 10.2169/internalmedicine.5097-20.
Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis
著者名：Takada S, Matsubara T, Fujii H, Sato-Matsubara M, Daikoku A, Odagiri N, Amano-Teranishi Y, Kawada N, Ikeda K.
出版物名：Lab Invest. 2021 Feb;101(2):193-203. doi: 10.1038/s41374-020-00509-x. Epub 2020 Dec 10.
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
著者名：Yoshida K, Enomoto M, Tamori A, Nishiguchi S, Kawada N.
出版物名：Int J Mol Sci. 2021 Feb 1;22(3):1456. doi: 10.3390/ijms22031456.
Regression of portal hypertension: underlying mechanisms and therapeutic strategies
著者名：Selicean S, Wang C, Guixé-Muntet S, Stefanescu H, Kawada N, Gracia-Sancho J.
出版物名：Hepatol Int. 2021 Feb;15(1):36-50. doi: 10.1007/s12072-021-10135-4. Epub 2021 Feb 5.
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
著者名：Liu M, Tseng TC, Jun DW, Yeh ML, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung M, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng CH, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH.
出版物名：Hepatol Int. 2021 Feb;15(1):71-81. doi: 10.1007/s12072-020-10113-2. Epub 2021 Jan 4.
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
著者名：Qi X, Liu Y, Wang J, Fallowfield JA, Wang J, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Li X, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Li X, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Li X, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC; COVID-Cirrhosis-CHESS Group.
出版物名：Gut. 2021 Feb;70(2):433-436. doi: 10.1136/gutjnl-2020-321666. Epub 2020 May 20.
Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines
著者名：Nishida N, Sugiyama M, Ohashi J, Kawai Y, Khor SS, Nishina S, Yamasaki K, Yazaki H, Okudera K, Tamori A, Eguchi Y, Sakai A, Kakisaka K, Sawai H, Tsuchiura T, Ishikawa M, Hino K, Sumazaki R, Takikawa Y, Kanda T, Yokosuka O, Yatsuhashi H, Tokunaga K, Mizokami M.
出版物名：Sci Rep. 2021 Mar 2;11(1):3703. doi: 10.1038/s41598-021-82986-8.
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas
著者名：Uchida-Kobayashi S, Kageyama K, Yamamoto A, Ikenaga H, Yoshida K, Kotani K, Kimura K, Odagiri N, Hagihara A, Fujii H, Enomoto M, Tamori A, Kubo S, Miki Y, Kawada N.
出版物名：Oncology. 2021;99(3):186-191. doi: 10.1159/000510911. Epub 2020 Oct 8.
Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry
著者名：Kurajoh M, Fukumoto S, Murase T, Nakamura T, Nagata Y, Nakatani S, Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Kawada N, Hirata K, Emoto M.
出版物名：Clin Chem Lab Med. 2020 Aug 1;59(4):e137-e140. doi: 10.1515/cclm-2020-0563. Print 2021 Mar 26.
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma
著者名：Kotani K, Uchida-Kobayashi S, Yoshida K, Kawamura E, Fujii H, Hagihara A, Enomoto M, Tamori A, Kawada N.
出版物名：Am J Gastroenterol. 2021 Apr;116(4):631. doi: 10.14309/ajg.0000000000000747.
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
著者名：Itakura J, Kurosaki M, Setoyama H, Simakami T, Oza N, Korenaga M, Tanaka M, Torimura T, Sakamoto N, Enomoto N, Ueno Y, Kawada N, Kaneko S, Nishiguchi S, Chayama K, Tanaka J, Izumi N, Kanto T.
出版物名：J Gastroenterol. 2021 May;56(5):470-478. doi: 10.1007/s00535-021-01782-3. Epub 2021 Mar 31.
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma
著者名：Matsui T, Hamada-Tsutsumi S, Naito Y, Nojima M, Iio E, Tamori A, Kubo S, Ide T, Kondo Y, Eguchi Y, Komori A, Morine Y, Shimada M, Utsunomiya T, Shirabe K, Kimura K, Hiasa Y, Chuaypen N, Tangkijvanich P, Naiki-Ito A, Takahashi S, Ochiya T, Tanaka Y.
出版物名：Hepatol Res. 2021 May 26. doi: 10.1111/hepr.13674. Online ahead of print.
Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles
著者名：Kitamura H, Tanaka F, Nadatani Y, Otani K, Hosomi S, Kamata N, Taira K, Nagami Y, Tanigawa T, Fukumoto S, Watanabe T, Kawada N, Fujiwara Y.
出版物名：J Clin Biochem Nutr. 2021 May;68(3):246-252. doi: 10.3164/jcbn.20-49. Epub 2020 Nov 14.
Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure
著者名：Cho Y, Kabata D, Ehara E, Yamamoto A, Mizuochi T, Mushiake S, Kusano H, Kuwae Y, Suzuki T, Uchida-Kobayashi S, Morikawa H, Amano-Teranishi Y, Kioka K, Jogo A, Isoura Y, Hamazaki T, Murakami Y, Tokuhara D.
出版物名：Hepatol Res. 2021 May;51(5):593-602. doi: 10.1111/hepr.13627. Epub 2021 Mar 6.
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir
著者名：Nguyen MH, Atsukawa M, Ishikawa T, Yasuda S, Yokohama K, Trinh HN, Arai T, Fukunishi S, Ogawa E, Hsu YC, Maeda M, Dang H, Tseng CH, Takahashi H, Jun DW, Watanabe T, Chuma M, Nozaki A, Kawada N, Cheung R, Enomoto M, Takaguchi K, Toyoda H.
出版物名：Am J Gastroenterol. 2021 Jun 1;116(6):1264-1273. doi: 10.14309/ajg.0000000000001157.
Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species.
著者名：Dat NQ, Thuy LTT, Hieu VN, Hai H, Hoang DV, Thi Thanh Hai N, Thuy TTV, Komiya T, Rombouts K, Dong MP, Hanh NV, Hoang TH, Sato-Matsubara M, Daikoku A, Kadono C, Oikawa D, Yoshizato K, Tokunaga F, Pinzani M, Kawada N.
出版物名：Hepatology. 2021 Jun;73(6):2527-2545. doi: 10.1002/hep.31752. Epub 2021 May 22.
Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein
著者名：Yamamoto A, Kawada N, Jogo A, Murai K, Kotani K, Kageyama K, Hamamoto S, Sohgawa E, Uchida-Kobayashi S, Enomoto M, Tamori A, Miki Y.
出版物名：Gut. 2021 Jun;70(6):1199-1201. doi: 10.1136/gutjnl-2020-322367. Epub 2020 Aug 18.
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation
著者名：Tamori A, Kimura K, Kioka K, Enomoto H, Odagiri N, Kozuka R, Uchida-Kobayashi S, Enomoto M, Kawada N, Mizokami M.
出版物名：J Med Virol. 2021 Jun;93(6):3679-3687. doi: 10.1002/jmv.26526. Epub 2020 Oct 5.
Validation of a two-step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
著者名：Fujii H, Enomoto M, Fukumoto S, Kimura T, Nadatani Y, Takashima S, Hagihara A, Uchida-Kobayashi S, Tamori A, Nishimoto N, Kawada N.
出版物名：JGH Open. 2021 Jun 10;5(7):801-808. doi: 10.1002/jgh3.12590. eCollection 2021 Jul.
Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan
著者名：Ohfuji S, Matsuura T, Tamori A, Kubo S, Sasaki S, Kondo K, Ito K, Fukushima W.
出版物名：Dig Dis Sci. 2021 Jun;66(6):2118-2128. doi: 10.1007/s10620-020-06475-0. Epub 2020 Jul 27.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine
著者名：Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng CH, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH.
出版物名：Clin Gastroenterol Hepatol. 2021 Jun 2;S1542-3565(21)00601-7. doi: 10.1016/j.cgh.2021.05.062. Online ahead of print.
A genome-wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites
著者名：Kawaratani H, Sawai H, Onishi M, Kogiso T, Shimada N, Uojima H, Nakajima T, Matsumoto N, Ikejima K, Ishikawa T, Terai S, Motoyama H, Komori A, Hirashima N, Saito S, Eguchi Y, Nojima M, Kawai Y, Tateyama M, Yoshiji H, Tanaka Y.
出版物名：Liver Int. 2021 Jul 26. doi: 10.1111/liv.15022. Online ahead of print.
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases
著者名：Fujii H, Fukumoto S, Enomoto M, Uchida-Kobayashi S, Kimura T, Tamori A, Nadatani Y, Takashima S, Nishimoto N, Kawada N.
出版物名：Sci Rep. 2021 Jul 5;11(1):13844. doi: 10.1038/s41598-021-93435-x.
Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient.
著者名：Suoh M, Hagihara A, Kageyama K, Yamamoto A, Enomoto M, Tamori A, Kawada N.
出版物名：Intern Med. 2021 Jul 15;60(14):2223-2228. doi: 10.2169/internalmedicine.6003-20. Epub 2021 Feb 22.
Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report
著者名：Kotani K, Uchida-Kobayashi S, Yamamoto A, Kawamura E, Enomoto M, Higashiyama S, Kawabe J, Shiomi S, Tamori A, Kawada N.
出版物名：Clin Physiol Funct Imaging. 2021 Jul;41(4):334-341. doi: 10.1111/cpf.12703. Epub 2021 Apr 29.
Anti-fibrotic treatments for chronic liver diseases: The present and the future
著者名：Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N.
出版物名：Clin Mol Hepatol. 2021 Jul;27(3):413-424. doi: 10.3350/cmh.2020.0187.
Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease
著者名：Shirai D, Shinkawa H, Takemura S, Tanaka S, Amano R, Kimura K, Kinoshita M, Kawada N, Kubo S.
出版物名：Ann Med Surg (Lond). 2021 Jul 29;68:102644. doi: 10.1016/j.amsu.2021.102644. eCollection 2021 Aug.
Half-Moon-shaped Aortic Arch Thrombosis Induced by Lenvatinib
著者名：Kotani K, Kawada N.
出版物名：Radiology. 2021 Aug;300(2):289. doi: 10.1148/radiol.2021204727. Epub 2021 Jun 15.
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C
著者名：Atsukawa M, Tsubota A, Kondo C, Uchida-Kobayashi S, Takaguchi K, Tsutsui A, Nozaki A, Chuma M, Hidaka I, Ishikawa T, Iwasa M, Tamai Y, Tobari M, Matsuura K, Nagura Y, Abe H, Kato K, Suzuki K, Okubo T, Arai T, Itokawa N, Toyoda H, Enomoto M, Tamori A, Tanaka Y, Kawada N, Takei Y, Iwakiri K.
出版物名：PLoS One. 2021 Sep 10;16(9):e0257166. doi: 10.1371/journal.pone.0257166. eCollection 2021.
The Albumin-bilirubin Score Detects Changes in the Liver Function During Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study
著者名：Kageyama K, Yamamoto A, Jogo A, Sohgawa E, Hagihara A, Fujii H, Uchida-Kobayashi S, Kawada N, Miki Y.
出版物名：Intern Med. 2021 Sep 18. doi: 10.2169/internalmedicine.8020-21. Online ahead of print.
A mask-based infection control method for screening endoscopy may prevent SARS-CoV-2 transmission and relieve staff anxiety
著者名：Nadatani Y, Higashimori A, Takashima S, Maruyama H, Otani K, Fukunaga S, Hosomi S, Tanaka F, Fujii H, Nakano A, Taira K, Kamata N, Nagami Y, Kimura T, Fukumoto S, Watanabe T, Kawada N, Fujiwara Y.
出版物名：SAGE Open Med. 2021 Sep 20;9:20503121211047060. doi: 10.1177/20503121211047060. eCollection 2021.
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
著者名：Huang CF, Jang TY, Jun DW, Ahn SB, An J, Enomoto M, Takahashi H, Ogawa E, Yoon E, Jeong SW, Shim JJ, Jeong JY, Kim SE, Oh H, Kim HS, Cho YK, Kozuka R, Inoue K, Cheung KS, Mak LY, Huang JF, Dai CY, Yuen MF, Nguyen MH, Yu ML.
出版物名：Liver Int. 2021 Oct 23. doi: 10.1111/liv.15085. Online ahead of print.
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment
著者名：Ikenaga H, Uchida-Kobayashi S, Tamori A, Odagiri N, Yoshida K, Kotani K, Motoyama H, Kozuka R, Kawamura E, Hagihara A, Fujii H, Enomoto M, Kawada N.
出版物名：J Viral Hepat. 2021 Oct 25. doi: 10.1111/jvh.13627. Online ahead of print.
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed
著者名：Nonomura A, Tamori A, Hai H, Kozuka R, Fujii H, Uchida-Kobayashi S, Enomoto M, Kawada N.
出版物名：Intern Med. 2021 Nov 1;60(21):3441-3445. doi: 10.2169/internalmedicine.7028-21. Epub 2021 May 22.
Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinoma
著者名：Tanaka S, Shinkawa H, Tamori A, Takemura S, Uchida-Kobayashi S, Amano R, Kimura K, Ohira G, Nishio K, Tauchi J, Kinoshita M, Kawada N, Kubo S.
出版物名：Hepatol Res. 2021 Nov;51(11):1102-1114. doi: 10.1111/hepr.13709. Epub 2021 Sep 21.
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study
著者名：Matsumoto K, Ohfuji S, Abe M, Komori A, Takahashi A, Fujii H, Kawata K, Noritake H, Tadokoro T, Honda A, Asami M, Namisaki T, Ueno M, Sato K, Kakisaka K, Arakawa M, Ito T, Tanaka K, Matsui T, Setsu T, Takamura M, Yasuda S, Katsumi T, Itakura J, Sano T, Tamura Y, Miura R, Arizumi T, Asaoka Y, Uno K, Nishitani A, Ueno Y, Terai S, Takikawa Y, Morimoto Y, Yoshiji H, Mochida S, Ikegami T, Masaki T, Kawada N, Ohira H, Tanaka A.
出版物名：J Gastroenterol. 2021 Nov 18. doi: 10.1007/s00535-021-01836-6. Online ahead of print.
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study
著者名：Mak LY, Hoang J, Jun DW, Chen CH, Peng CY, Yeh ML, Kim SE, Huang DQ, Jeong JY, Yoon E, Oh H, Tsai PC, Huang CF, Ahn SB, Trinh H, Xie Q, Wong GLH, Enomoto M, Shim JJ, Lee DH, Liu L, Kozuka R, Cho YK, Jeong SW, Kim HS, Trinh L, Dao A, Huang R, Hui RW, Tsui V, Quek S, Khine HHTW, Ogawa E, Dai CY, Huang JF, Cheung R, Wu C, Chuang WL, Lim SG, Yu ML, Yuen MF, Nguyen MH.
出版物名：Hepatol Int. 2021 Nov 25. doi: 10.1007/s12072-021-10271-x. Online ahead of print.
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
著者名：Hsu YC, Yeh ML, Wong GL, Chen CH, Peng CY, Buti M, Enomoto M, Xie Q, Trinh H, Preda C, Liu L, Cheung KS, Yeo YH, Hoang J, Huang CF, Riveiro-Barciela M, Kozuka R, Istratescu D, Tsai PC, Accarino EV, Lee DH, Wu JL, Huang JF, Dai CY, Cheung R, Chuang WL, Yuen MF, Wong VW, Yu ML, Nguyen MH.
出版物名：J Infect Dis. 2021 Dec 1;224(11):1890-1899. doi: 10.1093/infdis/jiab241.
I shall be released (from infinite HBV nucleos(t)ide analog therapy): Japanese experience
著者名：Enomoto M, Umemura T, Suzuki F.
出版物名：J Hepatol. 2021 Dec;75(6):1496-1497. doi: 10.1016/j.jhep.2021.07.002. Epub 2021 Jul 8.
Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals
著者名：Hidaka I, Enomoto M, Sato S, Suetsugu A, Matono T, Ito K, Ogawa K, Inoue J, Horino M, Kondo Y, Sakaida I, Korenaga M.
出版物名：Intern Med. 2021;60(3):337-343. doi: 10.2169/internalmedicine.4748-20. Epub 2021 Feb 1.
Role of vitamin E in the treatment of non-alcoholic steatohepatitis
著者名：Sumida Y, Yoneda M, Seko Y, Takahashi H, Hara N, Fujii H, Itoh Y, Yoneda M, Nakajima A, Okanoue T; Japan Study Group of NAFLD (JSG-NAFLD).
出版物名：Free Radic Biol Med. 2021 Dec;177:391-403. doi: 10.1016/j.freeradbiomed.2021.10.017. Epub 2021 Oct 29.
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment
著者名：Kozuka R, Enomoto M, Dong MP, Hai H, Thuy LTT, Odagiri N, Yoshida K, Kotani K, Motoyama H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, Tamori A, Kawada N
出版物名：Sci Rep. 2021 in press.

2021 和文

タイトル・著者

【肝類洞壁細胞研究における新知見】国際交流サロンとしての肝類洞壁細胞研究分野　過去・現在・未来(座談会/特集)
著者名：河田則文、稲垣豊、鳥村拓司
出版物名：肝胆膵（0389-4991）82巻4号 Page611-621（2021.04）
【肝・胆道系症候群(第3版)-その他の肝・胆道系疾患を含めて-肝臓編(下)】肝形成異常　異所性肝(異所性肝細胞癌を含めて)(解説/特集)
著者名：榎本大、林下晃士、打田佐和子、河田則文
出版物名：日本臨床（0047-1852）別冊肝・胆道系　症候群II Page105-107（2021.02）
【肝・胆道系症候群(第3版)-その他の肝・胆道系疾患を含めて-肝臓編(上)】感染症　その他の感染症　肝結核（解説/特集）
著者名：田守昭博、河田則文
出版物名：日本臨床（0047-1852）別冊肝・胆道系　症候群I Page96-99（2021.01）
【肝・胆道系症候群(第3版)-その他の肝・胆道系疾患を含めて-肝臓編(上)】感染症　ウイルス性肝炎　ヘルペスウイルス肝炎(サイトメガロウイルス)（解説/特集）
著者名：池永寛子、河田則文
出版物名：日本臨床（0047-1852）別冊肝・胆道系　症候群I Page46-49（2021.01）
肝疾患診療連携拠点病院における肝炎医療コーディネーターの現状(原著論文)
著者名：榎本大、日高勲、井上泰輔、磯田広史、井出達也、荒生祥尚、内田義人、井上貴子、池上正、柿崎暁、瀬戸山博子、島上哲朗、小川浩司、末次淳、井上淳、遠藤美月、永田賢治、是永匡紹
出版物名：肝臓（0451-4203）62巻2号 Page96-98（2021.02）
歯科の先生方にも知っておいて頂きたいB型・C型肝炎最新情報(解説)
著者名：榎本大
出版物名：大阪府歯科医師会雑誌（0912-2672）772号 Page32-45（2021.01）
【肝類洞壁細胞研究における新知見】肝の炎症、線維化と類洞壁細胞　サイトグロビンと肝の炎症、線維化(解説/特集)
著者名：松原三佐子
出版物名：肝胆膵（0389-4991）82巻4号 Page539-545（2021.04）
【膵癌研究最前線】膵星細胞に発現するサイトグロビンの膵癌における役割（解説/特集）
著者名：Le Thi Thanh Thuy、Hoang Hai、Dinh Viet Hoang、Ngo Vinh Hanh、打田佐和子（小林）、河田則文
出版物名：消化器・肝臓内科（2432-3446）10巻3号 Page354-362（2021.09）
【門脈圧亢進症up-to-date】門脈圧亢進症の成立機序と病態（解説/特集）
著者名：小谷晃平、河田則文
出版物名：消化器・肝臓内科（2432-3446）10巻1号 Page62-68（2021.07）
【肝疾患における食事・生活指導】禁酒・節酒指導　-少量飲酒は生命予後を改善するか？（解説/特集）
著者名：藤井英樹
出版物名：消化器・肝臓内科（2432-3446）10巻4号 Page495-499（2021.10）
肝線維化進行の機序
著者名：池永寛子、河田則文
出版物名：医学のあゆみ 279巻8号、770-773（2021）